Posted: 8 April 2022
Event Date: 12 April 2022
Dr Ian Nisbet Chief Operating Officer
Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner conference will explore stem cell therapeutics in the areas of regenerative medicine, oncology and emerging academic research. It will also showcase cutting-edge science, industry trends and the commercial potential of this innovative sector to an invited group of 65 life science investors.
Company participation in the conference is by invitation only. On Tuesday 12 April at 4:40 am AEST Ian will provide a non-confidential overview of Cartherics, its technology, lead product and pipeline, competitive position and more.
